Matches in DBpedia 2016-04 for { ?s ?p "The George Institute for Global Health is an independent medical research institute dedicated to improving global health. The George Institute conducts high impact research that targets preventable illnesses and injuries that are the leading causes of death and disability worldwide, including heart and kidney disease, stroke, diabetes, and injury. It is ranked in the top 10 research institutions in the world for research impact by the SCImago Institutions Rankings World Reports.The George Institute conducts research in more than 50 countries, with bases in Australia, China, India and the UK. The Institute’s global network conducts research that provides healthcare solutions for hospitals, clinics and medical facilities serving millions of people around the world.With a specific focus on the Asia Pacific regions, The Institute works to identify effective and affordable prevention and treatment strategies, and to strengthen health systems for disease and injury control through: Large-scale health research that provides the best possible evidence to treat the leading causes of death and disability Engaging with partners and decision makers to make changes to improve health outcomes, particularly in resource poor areas Building capacity among health professionals, healthcare providers and education for communities to ensure sustainable health outcomesSince 1999, The George has invested over $250 million across 50 countries. With over 450 staff globally, The Institute collaborates with some of the world’s leading universities, health professionals, hospitals and governments.Areas of expertise include: Chronic diseases, such as heart disease, kidney disease, diabetes and stroke Injury prevention, including road safety, falls prevention and frailty management in an effort to avoid disabilityFounded by Professors Stephen MacMahon and Robyn Norton, The George is affiliated with the universities of Sydney, Peking, and Oxford. The George Institute is currently chaired by Mike Hawker AM and The Institute’s board members are business and scientific leaders in both Australia and internationally.The George employs world-leading scientific experts and has an enviable research track record. The George Institute is one of only three academic research organisations (ARO) accredited to run clinical trials, which ensure unbiased rigor and improved ability to disseminate findings, with the other two AROs being the University of Oxford in the UK and Duke University in the USA.The institute has had major scientific outputs in publications including The Lancet, The New England Journal of Medicine, PLoS ONE Journal, Heart (formerly British Heart Journal) and more."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- George_Institute_for_Global_Health abstract "The George Institute for Global Health is an independent medical research institute dedicated to improving global health. The George Institute conducts high impact research that targets preventable illnesses and injuries that are the leading causes of death and disability worldwide, including heart and kidney disease, stroke, diabetes, and injury. It is ranked in the top 10 research institutions in the world for research impact by the SCImago Institutions Rankings World Reports.The George Institute conducts research in more than 50 countries, with bases in Australia, China, India and the UK. The Institute’s global network conducts research that provides healthcare solutions for hospitals, clinics and medical facilities serving millions of people around the world.With a specific focus on the Asia Pacific regions, The Institute works to identify effective and affordable prevention and treatment strategies, and to strengthen health systems for disease and injury control through: Large-scale health research that provides the best possible evidence to treat the leading causes of death and disability Engaging with partners and decision makers to make changes to improve health outcomes, particularly in resource poor areas Building capacity among health professionals, healthcare providers and education for communities to ensure sustainable health outcomesSince 1999, The George has invested over $250 million across 50 countries. With over 450 staff globally, The Institute collaborates with some of the world’s leading universities, health professionals, hospitals and governments.Areas of expertise include: Chronic diseases, such as heart disease, kidney disease, diabetes and stroke Injury prevention, including road safety, falls prevention and frailty management in an effort to avoid disabilityFounded by Professors Stephen MacMahon and Robyn Norton, The George is affiliated with the universities of Sydney, Peking, and Oxford. The George Institute is currently chaired by Mike Hawker AM and The Institute’s board members are business and scientific leaders in both Australia and internationally.The George employs world-leading scientific experts and has an enviable research track record. The George Institute is one of only three academic research organisations (ARO) accredited to run clinical trials, which ensure unbiased rigor and improved ability to disseminate findings, with the other two AROs being the University of Oxford in the UK and Duke University in the USA.The institute has had major scientific outputs in publications including The Lancet, The New England Journal of Medicine, PLoS ONE Journal, Heart (formerly British Heart Journal) and more.".
- Q7736177 abstract "The George Institute for Global Health is an independent medical research institute dedicated to improving global health. The George Institute conducts high impact research that targets preventable illnesses and injuries that are the leading causes of death and disability worldwide, including heart and kidney disease, stroke, diabetes, and injury. It is ranked in the top 10 research institutions in the world for research impact by the SCImago Institutions Rankings World Reports.The George Institute conducts research in more than 50 countries, with bases in Australia, China, India and the UK. The Institute’s global network conducts research that provides healthcare solutions for hospitals, clinics and medical facilities serving millions of people around the world.With a specific focus on the Asia Pacific regions, The Institute works to identify effective and affordable prevention and treatment strategies, and to strengthen health systems for disease and injury control through: Large-scale health research that provides the best possible evidence to treat the leading causes of death and disability Engaging with partners and decision makers to make changes to improve health outcomes, particularly in resource poor areas Building capacity among health professionals, healthcare providers and education for communities to ensure sustainable health outcomesSince 1999, The George has invested over $250 million across 50 countries. With over 450 staff globally, The Institute collaborates with some of the world’s leading universities, health professionals, hospitals and governments.Areas of expertise include: Chronic diseases, such as heart disease, kidney disease, diabetes and stroke Injury prevention, including road safety, falls prevention and frailty management in an effort to avoid disabilityFounded by Professors Stephen MacMahon and Robyn Norton, The George is affiliated with the universities of Sydney, Peking, and Oxford. The George Institute is currently chaired by Mike Hawker AM and The Institute’s board members are business and scientific leaders in both Australia and internationally.The George employs world-leading scientific experts and has an enviable research track record. The George Institute is one of only three academic research organisations (ARO) accredited to run clinical trials, which ensure unbiased rigor and improved ability to disseminate findings, with the other two AROs being the University of Oxford in the UK and Duke University in the USA.The institute has had major scientific outputs in publications including The Lancet, The New England Journal of Medicine, PLoS ONE Journal, Heart (formerly British Heart Journal) and more.".